nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2C9—Teniposide—lymphatic system cancer	0.102	0.35	CbGbCtD
Donepezil—CYP3A4—Cytarabine—lymphatic system cancer	0.0603	0.207	CbGbCtD
Donepezil—CYP3A4—Teniposide—lymphatic system cancer	0.0594	0.203	CbGbCtD
Donepezil—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0415	0.142	CbGbCtD
Donepezil—CYP3A4—Vincristine—lymphatic system cancer	0.0286	0.0979	CbGbCtD
Donepezil—Alopecia—Carmustine—lymphatic system cancer	0.000954	0.00135	CcSEcCtD
Donepezil—Body temperature increased—Fludarabine—lymphatic system cancer	0.000947	0.00134	CcSEcCtD
Donepezil—Mental disorder—Carmustine—lymphatic system cancer	0.000946	0.00134	CcSEcCtD
Donepezil—Vaginal infection—Methotrexate—lymphatic system cancer	0.00094	0.00133	CcSEcCtD
Donepezil—Malnutrition—Carmustine—lymphatic system cancer	0.00094	0.00133	CcSEcCtD
Donepezil—Erythema—Carmustine—lymphatic system cancer	0.00094	0.00133	CcSEcCtD
Donepezil—Cough—Bleomycin—lymphatic system cancer	0.000939	0.00133	CcSEcCtD
Donepezil—Diarrhoea—Teniposide—lymphatic system cancer	0.000933	0.00132	CcSEcCtD
Donepezil—Chest pain—Bleomycin—lymphatic system cancer	0.000916	0.00129	CcSEcCtD
Donepezil—Myalgia—Bleomycin—lymphatic system cancer	0.000916	0.00129	CcSEcCtD
Donepezil—Alopecia—Vincristine—lymphatic system cancer	0.00091	0.00129	CcSEcCtD
Donepezil—Back pain—Carmustine—lymphatic system cancer	0.000909	0.00128	CcSEcCtD
Donepezil—Discomfort—Bleomycin—lymphatic system cancer	0.000905	0.00128	CcSEcCtD
Donepezil—Mental disorder—Vincristine—lymphatic system cancer	0.000903	0.00127	CcSEcCtD
Donepezil—Chills—Mitoxantrone—lymphatic system cancer	0.0009	0.00127	CcSEcCtD
Donepezil—Ecchymosis—Methotrexate—lymphatic system cancer	0.0009	0.00127	CcSEcCtD
Donepezil—Bladder pain—Methotrexate—lymphatic system cancer	0.0009	0.00127	CcSEcCtD
Donepezil—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000896	0.00127	CcSEcCtD
Donepezil—Alopecia—Mitoxantrone—lymphatic system cancer	0.000887	0.00125	CcSEcCtD
Donepezil—Confusional state—Bleomycin—lymphatic system cancer	0.000886	0.00125	CcSEcCtD
Donepezil—Vision blurred—Carmustine—lymphatic system cancer	0.000885	0.00125	CcSEcCtD
Donepezil—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000883	0.00125	CcSEcCtD
Donepezil—Tremor—Carmustine—lymphatic system cancer	0.00088	0.00124	CcSEcCtD
Donepezil—Oedema—Bleomycin—lymphatic system cancer	0.000878	0.00124	CcSEcCtD
Donepezil—Erythema—Mitoxantrone—lymphatic system cancer	0.000873	0.00123	CcSEcCtD
Donepezil—Infection—Bleomycin—lymphatic system cancer	0.000873	0.00123	CcSEcCtD
Donepezil—Anaemia—Carmustine—lymphatic system cancer	0.000868	0.00123	CcSEcCtD
Donepezil—Back pain—Vincristine—lymphatic system cancer	0.000868	0.00123	CcSEcCtD
Donepezil—Vomiting—Teniposide—lymphatic system cancer	0.000867	0.00122	CcSEcCtD
Donepezil—Sepsis—Methotrexate—lymphatic system cancer	0.000864	0.00122	CcSEcCtD
Donepezil—Agitation—Carmustine—lymphatic system cancer	0.000863	0.00122	CcSEcCtD
Donepezil—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00086	0.00121	CcSEcCtD
Donepezil—Asthenia—Fludarabine—lymphatic system cancer	0.00086	0.00121	CcSEcCtD
Donepezil—Rash—Teniposide—lymphatic system cancer	0.00086	0.00121	CcSEcCtD
Donepezil—Dermatitis—Teniposide—lymphatic system cancer	0.000859	0.00121	CcSEcCtD
Donepezil—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000855	0.00121	CcSEcCtD
Donepezil—Headache—Teniposide—lymphatic system cancer	0.000854	0.00121	CcSEcCtD
Donepezil—Pruritus—Fludarabine—lymphatic system cancer	0.000848	0.0012	CcSEcCtD
Donepezil—Back pain—Mitoxantrone—lymphatic system cancer	0.000845	0.00119	CcSEcCtD
Donepezil—Anorexia—Bleomycin—lymphatic system cancer	0.000837	0.00118	CcSEcCtD
Donepezil—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000831	0.00117	CcSEcCtD
Donepezil—Anaemia—Vincristine—lymphatic system cancer	0.000829	0.00117	CcSEcCtD
Donepezil—Agitation—Vincristine—lymphatic system cancer	0.000824	0.00116	CcSEcCtD
Donepezil—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000823	0.00116	CcSEcCtD
Donepezil—Hypotension—Bleomycin—lymphatic system cancer	0.000821	0.00116	CcSEcCtD
Donepezil—Diarrhoea—Fludarabine—lymphatic system cancer	0.00082	0.00116	CcSEcCtD
Donepezil—Convulsion—Carmustine—lymphatic system cancer	0.000814	0.00115	CcSEcCtD
Donepezil—Hypertension—Carmustine—lymphatic system cancer	0.000811	0.00115	CcSEcCtD
Donepezil—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00081	0.00114	CcSEcCtD
Donepezil—Nausea—Teniposide—lymphatic system cancer	0.00081	0.00114	CcSEcCtD
Donepezil—Anaemia—Mitoxantrone—lymphatic system cancer	0.000807	0.00114	CcSEcCtD
Donepezil—Vertigo—Vincristine—lymphatic system cancer	0.000806	0.00114	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0008	0.00113	CcSEcCtD
Donepezil—Myalgia—Carmustine—lymphatic system cancer	0.0008	0.00113	CcSEcCtD
Donepezil—Chest pain—Carmustine—lymphatic system cancer	0.0008	0.00113	CcSEcCtD
Donepezil—Anxiety—Carmustine—lymphatic system cancer	0.000797	0.00113	CcSEcCtD
Donepezil—Paraesthesia—Bleomycin—lymphatic system cancer	0.000789	0.00111	CcSEcCtD
Donepezil—Malaise—Mitoxantrone—lymphatic system cancer	0.000788	0.00111	CcSEcCtD
Donepezil—Dyspnoea—Bleomycin—lymphatic system cancer	0.000783	0.00111	CcSEcCtD
Donepezil—Convulsion—Vincristine—lymphatic system cancer	0.000777	0.0011	CcSEcCtD
Donepezil—Hypertension—Vincristine—lymphatic system cancer	0.000774	0.00109	CcSEcCtD
Donepezil—Confusional state—Carmustine—lymphatic system cancer	0.000773	0.00109	CcSEcCtD
Donepezil—Oedema—Carmustine—lymphatic system cancer	0.000767	0.00108	CcSEcCtD
Donepezil—Decreased appetite—Bleomycin—lymphatic system cancer	0.000764	0.00108	CcSEcCtD
Donepezil—Myalgia—Vincristine—lymphatic system cancer	0.000764	0.00108	CcSEcCtD
Donepezil—Cough—Mitoxantrone—lymphatic system cancer	0.000762	0.00108	CcSEcCtD
Donepezil—Infection—Carmustine—lymphatic system cancer	0.000762	0.00108	CcSEcCtD
Donepezil—Vomiting—Fludarabine—lymphatic system cancer	0.000762	0.00108	CcSEcCtD
Donepezil—Convulsion—Mitoxantrone—lymphatic system cancer	0.000757	0.00107	CcSEcCtD
Donepezil—Rash—Fludarabine—lymphatic system cancer	0.000755	0.00107	CcSEcCtD
Donepezil—Dermatitis—Fludarabine—lymphatic system cancer	0.000755	0.00107	CcSEcCtD
Donepezil—Hypertension—Mitoxantrone—lymphatic system cancer	0.000754	0.00106	CcSEcCtD
Donepezil—Pain—Bleomycin—lymphatic system cancer	0.000751	0.00106	CcSEcCtD
Donepezil—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000751	0.00106	CcSEcCtD
Donepezil—Headache—Fludarabine—lymphatic system cancer	0.000751	0.00106	CcSEcCtD
Donepezil—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000744	0.00105	CcSEcCtD
Donepezil—Chest pain—Mitoxantrone—lymphatic system cancer	0.000744	0.00105	CcSEcCtD
Donepezil—Myalgia—Mitoxantrone—lymphatic system cancer	0.000744	0.00105	CcSEcCtD
Donepezil—Anxiety—Mitoxantrone—lymphatic system cancer	0.000741	0.00105	CcSEcCtD
Donepezil—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000737	0.00104	CcSEcCtD
Donepezil—Discomfort—Mitoxantrone—lymphatic system cancer	0.000735	0.00104	CcSEcCtD
Donepezil—Oedema—Vincristine—lymphatic system cancer	0.000732	0.00103	CcSEcCtD
Donepezil—Anorexia—Carmustine—lymphatic system cancer	0.000731	0.00103	CcSEcCtD
Donepezil—Infection—Vincristine—lymphatic system cancer	0.000727	0.00103	CcSEcCtD
Donepezil—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000724	0.00102	CcSEcCtD
Donepezil—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000723	0.00102	CcSEcCtD
Donepezil—Confusional state—Mitoxantrone—lymphatic system cancer	0.000719	0.00101	CcSEcCtD
Donepezil—Nervous system disorder—Vincristine—lymphatic system cancer	0.000718	0.00101	CcSEcCtD
Donepezil—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000717	0.00101	CcSEcCtD
Donepezil—Hypotension—Carmustine—lymphatic system cancer	0.000716	0.00101	CcSEcCtD
Donepezil—Oedema—Mitoxantrone—lymphatic system cancer	0.000713	0.00101	CcSEcCtD
Donepezil—Nausea—Fludarabine—lymphatic system cancer	0.000712	0.001	CcSEcCtD
Donepezil—Infection—Mitoxantrone—lymphatic system cancer	0.000708	0.001	CcSEcCtD
Donepezil—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000708	0.000999	CcSEcCtD
Donepezil—Shock—Mitoxantrone—lymphatic system cancer	0.000701	0.00099	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000699	0.000986	CcSEcCtD
Donepezil—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000698	0.000986	CcSEcCtD
Donepezil—Urticaria—Bleomycin—lymphatic system cancer	0.000698	0.000985	CcSEcCtD
Donepezil—Anorexia—Vincristine—lymphatic system cancer	0.000698	0.000985	CcSEcCtD
Donepezil—Body temperature increased—Bleomycin—lymphatic system cancer	0.000694	0.000981	CcSEcCtD
Donepezil—Insomnia—Carmustine—lymphatic system cancer	0.000694	0.000979	CcSEcCtD
Donepezil—Irritability—Methotrexate—lymphatic system cancer	0.00069	0.000974	CcSEcCtD
Donepezil—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000689	0.000973	CcSEcCtD
Donepezil—Paraesthesia—Carmustine—lymphatic system cancer	0.000689	0.000972	CcSEcCtD
Donepezil—Mood swings—Methotrexate—lymphatic system cancer	0.000685	0.000967	CcSEcCtD
Donepezil—Hypotension—Vincristine—lymphatic system cancer	0.000684	0.000966	CcSEcCtD
Donepezil—Dyspnoea—Carmustine—lymphatic system cancer	0.000684	0.000965	CcSEcCtD
Donepezil—Somnolence—Carmustine—lymphatic system cancer	0.000682	0.000963	CcSEcCtD
Donepezil—Anorexia—Mitoxantrone—lymphatic system cancer	0.000679	0.00096	CcSEcCtD
Donepezil—Ataxia—Methotrexate—lymphatic system cancer	0.000679	0.000959	CcSEcCtD
Donepezil—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000667	0.000942	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000667	0.000942	CcSEcCtD
Donepezil—Decreased appetite—Carmustine—lymphatic system cancer	0.000667	0.000941	CcSEcCtD
Donepezil—Hypotension—Mitoxantrone—lymphatic system cancer	0.000666	0.000941	CcSEcCtD
Donepezil—Insomnia—Vincristine—lymphatic system cancer	0.000662	0.000935	CcSEcCtD
Donepezil—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000662	0.000935	CcSEcCtD
Donepezil—Paraesthesia—Vincristine—lymphatic system cancer	0.000657	0.000928	CcSEcCtD
Donepezil—Pain—Carmustine—lymphatic system cancer	0.000656	0.000926	CcSEcCtD
Donepezil—Constipation—Carmustine—lymphatic system cancer	0.000656	0.000926	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000649	0.000917	CcSEcCtD
Donepezil—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000647	0.000914	CcSEcCtD
Donepezil—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00064	0.000904	CcSEcCtD
Donepezil—Decreased appetite—Vincristine—lymphatic system cancer	0.000636	0.000899	CcSEcCtD
Donepezil—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000636	0.000897	CcSEcCtD
Donepezil—Somnolence—Mitoxantrone—lymphatic system cancer	0.000634	0.000895	CcSEcCtD
Donepezil—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000632	0.000892	CcSEcCtD
Donepezil—Feeling abnormal—Carmustine—lymphatic system cancer	0.000632	0.000892	CcSEcCtD
Donepezil—Fatigue—Vincristine—lymphatic system cancer	0.000631	0.000891	CcSEcCtD
Donepezil—Asthenia—Bleomycin—lymphatic system cancer	0.00063	0.00089	CcSEcCtD
Donepezil—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000627	0.000886	CcSEcCtD
Donepezil—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000627	0.000885	CcSEcCtD
Donepezil—Pain—Vincristine—lymphatic system cancer	0.000626	0.000884	CcSEcCtD
Donepezil—Constipation—Vincristine—lymphatic system cancer	0.000626	0.000884	CcSEcCtD
Donepezil—Asthma—Methotrexate—lymphatic system cancer	0.000625	0.000882	CcSEcCtD
Donepezil—Pruritus—Bleomycin—lymphatic system cancer	0.000621	0.000878	CcSEcCtD
Donepezil—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00062	0.000875	CcSEcCtD
Donepezil—Eosinophilia—Methotrexate—lymphatic system cancer	0.000618	0.000873	CcSEcCtD
Donepezil—Fatigue—Mitoxantrone—lymphatic system cancer	0.000615	0.000868	CcSEcCtD
Donepezil—Pancreatitis—Methotrexate—lymphatic system cancer	0.000612	0.000865	CcSEcCtD
Donepezil—Pain—Mitoxantrone—lymphatic system cancer	0.00061	0.000861	CcSEcCtD
Donepezil—Constipation—Mitoxantrone—lymphatic system cancer	0.00061	0.000861	CcSEcCtD
Donepezil—Body temperature increased—Carmustine—lymphatic system cancer	0.000606	0.000856	CcSEcCtD
Donepezil—Abdominal pain—Carmustine—lymphatic system cancer	0.000606	0.000856	CcSEcCtD
Donepezil—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000599	0.000845	CcSEcCtD
Donepezil—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000599	0.000845	CcSEcCtD
Donepezil—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000587	0.00083	CcSEcCtD
Donepezil—Dysuria—Methotrexate—lymphatic system cancer	0.000584	0.000825	CcSEcCtD
Donepezil—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000583	0.000823	CcSEcCtD
Donepezil—Abdominal pain—Vincristine—lymphatic system cancer	0.000579	0.000817	CcSEcCtD
Donepezil—Body temperature increased—Vincristine—lymphatic system cancer	0.000579	0.000817	CcSEcCtD
Donepezil—Urticaria—Mitoxantrone—lymphatic system cancer	0.000566	0.0008	CcSEcCtD
Donepezil—Hypersensitivity—Carmustine—lymphatic system cancer	0.000565	0.000798	CcSEcCtD
Donepezil—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000564	0.000796	CcSEcCtD
Donepezil—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000564	0.000796	CcSEcCtD
Donepezil—Pneumonia—Methotrexate—lymphatic system cancer	0.00056	0.000791	CcSEcCtD
Donepezil—Vomiting—Bleomycin—lymphatic system cancer	0.000559	0.000789	CcSEcCtD
Donepezil—Infestation NOS—Methotrexate—lymphatic system cancer	0.000557	0.000786	CcSEcCtD
Donepezil—Infestation—Methotrexate—lymphatic system cancer	0.000557	0.000786	CcSEcCtD
Donepezil—Depression—Methotrexate—lymphatic system cancer	0.000555	0.000784	CcSEcCtD
Donepezil—Rash—Bleomycin—lymphatic system cancer	0.000554	0.000782	CcSEcCtD
Donepezil—Dermatitis—Bleomycin—lymphatic system cancer	0.000553	0.000781	CcSEcCtD
Donepezil—Asthenia—Carmustine—lymphatic system cancer	0.00055	0.000777	CcSEcCtD
Donepezil—Renal failure—Methotrexate—lymphatic system cancer	0.000547	0.000773	CcSEcCtD
Donepezil—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000541	0.000764	CcSEcCtD
Donepezil—Hypersensitivity—Vincristine—lymphatic system cancer	0.000539	0.000762	CcSEcCtD
Donepezil—Sweating—Methotrexate—lymphatic system cancer	0.000534	0.000754	CcSEcCtD
Donepezil—Haematuria—Methotrexate—lymphatic system cancer	0.000531	0.00075	CcSEcCtD
Donepezil—Epistaxis—Methotrexate—lymphatic system cancer	0.000525	0.000742	CcSEcCtD
Donepezil—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000525	0.000742	CcSEcCtD
Donepezil—Asthenia—Vincristine—lymphatic system cancer	0.000525	0.000742	CcSEcCtD
Donepezil—Diarrhoea—Carmustine—lymphatic system cancer	0.000525	0.000741	CcSEcCtD
Donepezil—Nausea—Bleomycin—lymphatic system cancer	0.000522	0.000737	CcSEcCtD
Donepezil—Asthenia—Mitoxantrone—lymphatic system cancer	0.000511	0.000722	CcSEcCtD
Donepezil—Dizziness—Carmustine—lymphatic system cancer	0.000507	0.000716	CcSEcCtD
Donepezil—Haemoglobin—Methotrexate—lymphatic system cancer	0.000502	0.00071	CcSEcCtD
Donepezil—Diarrhoea—Vincristine—lymphatic system cancer	0.000501	0.000707	CcSEcCtD
Donepezil—Haemorrhage—Methotrexate—lymphatic system cancer	0.0005	0.000706	CcSEcCtD
Donepezil—Hepatitis—Methotrexate—lymphatic system cancer	0.0005	0.000706	CcSEcCtD
Donepezil—Pharyngitis—Methotrexate—lymphatic system cancer	0.000496	0.000701	CcSEcCtD
Donepezil—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000494	0.000697	CcSEcCtD
Donepezil—Urethral disorder—Methotrexate—lymphatic system cancer	0.00049	0.000692	CcSEcCtD
Donepezil—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000488	0.000689	CcSEcCtD
Donepezil—Vomiting—Carmustine—lymphatic system cancer	0.000488	0.000688	CcSEcCtD
Donepezil—Dizziness—Vincristine—lymphatic system cancer	0.000484	0.000684	CcSEcCtD
Donepezil—Rash—Carmustine—lymphatic system cancer	0.000483	0.000683	CcSEcCtD
Donepezil—Dermatitis—Carmustine—lymphatic system cancer	0.000483	0.000682	CcSEcCtD
Donepezil—Visual impairment—Methotrexate—lymphatic system cancer	0.000482	0.00068	CcSEcCtD
Donepezil—Headache—Carmustine—lymphatic system cancer	0.00048	0.000678	CcSEcCtD
Donepezil—Tinnitus—Methotrexate—lymphatic system cancer	0.000466	0.000658	CcSEcCtD
Donepezil—Vomiting—Vincristine—lymphatic system cancer	0.000465	0.000657	CcSEcCtD
Donepezil—Rash—Vincristine—lymphatic system cancer	0.000462	0.000652	CcSEcCtD
Donepezil—Dermatitis—Vincristine—lymphatic system cancer	0.000461	0.000651	CcSEcCtD
Donepezil—Headache—Vincristine—lymphatic system cancer	0.000459	0.000648	CcSEcCtD
Donepezil—Nausea—Carmustine—lymphatic system cancer	0.000455	0.000643	CcSEcCtD
Donepezil—Vomiting—Mitoxantrone—lymphatic system cancer	0.000453	0.00064	CcSEcCtD
Donepezil—Rash—Mitoxantrone—lymphatic system cancer	0.000449	0.000635	CcSEcCtD
Donepezil—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000449	0.000634	CcSEcCtD
Donepezil—Chills—Methotrexate—lymphatic system cancer	0.000449	0.000633	CcSEcCtD
Donepezil—Headache—Mitoxantrone—lymphatic system cancer	0.000447	0.000631	CcSEcCtD
Donepezil—Alopecia—Methotrexate—lymphatic system cancer	0.000442	0.000624	CcSEcCtD
Donepezil—Mental disorder—Methotrexate—lymphatic system cancer	0.000438	0.000618	CcSEcCtD
Donepezil—Malnutrition—Methotrexate—lymphatic system cancer	0.000435	0.000615	CcSEcCtD
Donepezil—Erythema—Methotrexate—lymphatic system cancer	0.000435	0.000615	CcSEcCtD
Donepezil—Nausea—Vincristine—lymphatic system cancer	0.000435	0.000614	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—lymphatic system cancer	0.000426	0.000602	CcSEcCtD
Donepezil—Nausea—Mitoxantrone—lymphatic system cancer	0.000423	0.000598	CcSEcCtD
Donepezil—Back pain—Methotrexate—lymphatic system cancer	0.000421	0.000594	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—lymphatic system cancer	0.00041	0.000579	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000404	0.00057	CcSEcCtD
Donepezil—Anaemia—Methotrexate—lymphatic system cancer	0.000402	0.000568	CcSEcCtD
Donepezil—Malaise—Methotrexate—lymphatic system cancer	0.000392	0.000554	CcSEcCtD
Donepezil—Vertigo—Methotrexate—lymphatic system cancer	0.000391	0.000552	CcSEcCtD
Donepezil—Cough—Methotrexate—lymphatic system cancer	0.00038	0.000536	CcSEcCtD
Donepezil—Convulsion—Methotrexate—lymphatic system cancer	0.000377	0.000532	CcSEcCtD
Donepezil—Myalgia—Methotrexate—lymphatic system cancer	0.00037	0.000523	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—lymphatic system cancer	0.00037	0.000523	CcSEcCtD
Donepezil—Chest pain—Methotrexate—lymphatic system cancer	0.00037	0.000523	CcSEcCtD
Donepezil—Discomfort—Methotrexate—lymphatic system cancer	0.000366	0.000517	CcSEcCtD
Donepezil—Confusional state—Methotrexate—lymphatic system cancer	0.000358	0.000506	CcSEcCtD
Donepezil—Infection—Methotrexate—lymphatic system cancer	0.000353	0.000498	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000348	0.000492	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000348	0.000491	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000343	0.000485	CcSEcCtD
Donepezil—Anorexia—Methotrexate—lymphatic system cancer	0.000339	0.000478	CcSEcCtD
Donepezil—Hypotension—Methotrexate—lymphatic system cancer	0.000332	0.000469	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000324	0.000457	CcSEcCtD
Donepezil—Insomnia—Methotrexate—lymphatic system cancer	0.000321	0.000454	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—lymphatic system cancer	0.000319	0.00045	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—lymphatic system cancer	0.000317	0.000447	CcSEcCtD
Donepezil—Somnolence—Methotrexate—lymphatic system cancer	0.000316	0.000446	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—lymphatic system cancer	0.000313	0.000441	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—lymphatic system cancer	0.000309	0.000436	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000307	0.000433	CcSEcCtD
Donepezil—Fatigue—Methotrexate—lymphatic system cancer	0.000306	0.000432	CcSEcCtD
Donepezil—Pain—Methotrexate—lymphatic system cancer	0.000304	0.000429	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000293	0.000413	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00029	0.00041	CcSEcCtD
Donepezil—Urticaria—Methotrexate—lymphatic system cancer	0.000282	0.000398	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—lymphatic system cancer	0.000281	0.000396	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—lymphatic system cancer	0.000281	0.000396	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000262	0.00037	CcSEcCtD
Donepezil—Asthenia—Methotrexate—lymphatic system cancer	0.000255	0.00036	CcSEcCtD
Donepezil—Pruritus—Methotrexate—lymphatic system cancer	0.000251	0.000355	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—lymphatic system cancer	0.000243	0.000343	CcSEcCtD
Donepezil—Dizziness—Methotrexate—lymphatic system cancer	0.000235	0.000332	CcSEcCtD
Donepezil—Vomiting—Methotrexate—lymphatic system cancer	0.000226	0.000319	CcSEcCtD
Donepezil—Rash—Methotrexate—lymphatic system cancer	0.000224	0.000316	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—lymphatic system cancer	0.000224	0.000316	CcSEcCtD
Donepezil—Headache—Methotrexate—lymphatic system cancer	0.000222	0.000314	CcSEcCtD
Donepezil—Nausea—Methotrexate—lymphatic system cancer	0.000211	0.000298	CcSEcCtD
